Clearmind Medicine (CMND) Current Assets (2021 - 2026)
Clearmind Medicine (CMND) posted quarterly Current Assets of $14.3 million for Q2 2026, up 185.16% year-over-year from $5.0 million in Q2 2025, and up 29.96% quarter-over-quarter from $11.0 million in Q1 2026.
Clearmind Medicine (CMND) Current Assets (2021 - 2026) Analysis & Trends
Clearmind Medicine's Current Assets history runs 6 years deep, the most recent figure standing at $14.3 million for Q2 2026.
- In Q2 2026, Current Assets rose 185.16% year-over-year to $14.3 million; the TTM figure through Apr 2026 stood at $14.3 million (up 185.16% YoY), while the FY2025 annual figure was $5.9 million, down 16.09% from the prior year.
- Current Assets for Q2 2026 stood at $14.3 million, up from $11.0 million in the prior quarter.
- The five-year high for Current Assets was $14.3 million in Q2 2026, with the low at $446701.9 in Q4 2022.
- The 5-year median for Current Assets is $5.9 million (2025), against an average of $6.7 million.
- The sharpest annual moves came in 2022 and 2023: Current Assets tumbled 88.59% in 2022, then jumped 1197.19% in 2023.
- Clearmind Medicine's Current Assets stood at $446701.9 in 2022, then surged by 1197.19% to $5.8 million in 2023, then climbed by 22.33% to $7.1 million in 2024, then slipped by 16.09% to $5.9 million in 2025, then soared by 140.81% to $14.3 million in 2026.
- Business Quant data shows CMND's Current Assets at $14.3 million in Q2 2026, $11.0 million in Q1 2026, and $5.9 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.93 Bn | 131.07 Bn | 2.84 Bn | 12.54 Bn |
| 2 | Regeneron Pharmaceuticals | 85.91 Bn | 77.92 Bn | 3.93 Bn | 18.45 Bn |
| 3 | Argenx Se | 64.98 Bn | 59.80 Bn | 1.37 Bn | 8.07 Bn |
| 4 | Moderna | 58.86 Bn | 53.72 Bn | 52.00 Mn | 5.82 Bn |
| 5 | BeOne Medicines | 42.03 Bn | 36.93 Bn | 1.53 Bn | 7.22 Bn |
| 6 | Alnylam Pharmaceuticals | 31.54 Bn | 28.23 Bn | 992.69 Mn | 4.62 Bn |
| 7 | BioNTech SE | 27.88 Bn | 9.49 Bn | 668.28 Mn | 18.80 Bn |
| 8 | Insmed | 27.44 Bn | 26.28 Bn | 358.27 Mn | 1.63 Bn |
| 9 | Royalty Pharma | 27.35 Bn | 26.51 Bn | - | 1.76 Bn |
| 10 | Clearmind Medicine | 540,485.35 | -13.05 Mn | - | 14.32 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | 14.32 Mn |
| Jan 31, 2026 | 11.02 Mn |
| Oct 31, 2025 | 5.95 Mn |
| Jul 31, 2025 | 3.82 Mn |
| Apr 30, 2025 | 5.02 Mn |
| Jan 31, 2025 | 6.41 Mn |
| Oct 31, 2024 | 7.09 Mn |
| Jul 31, 2024 | 7.99 Mn |
| Apr 30, 2024 | 8.69 Mn |
| Jan 31, 2024 | 9.84 Mn |
| Oct 31, 2023 | 5.79 Mn |
| Jul 31, 2023 | 4.36 Mn |
| Apr 30, 2023 | 5.84 Mn |
| Jan 31, 2023 | 4.43 Mn |
| Oct 31, 2022 | 446,701.89 |
| Oct 31, 2021 | 3.91 Mn |